Lack of association between carotid intima-media thickness and apolipoprotein (a) isoforms in a sample of Spanish general population

Journal of Cardiology

Volumn 61, Issue 5, 2013, Pages 372-377

  Calmarza, Pilar ^a   Trejo, Jose M ^b   Lapresta, Carlos ^a   Lopez, Pilar ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b Research Unit   (Spain)

Author keywords

Apolipoprotein (a) phenotypes; Carotid artery; Early atherosclerosis; Intima media thickness; Lipoprotein (a)

Indexed keywords

APOLIPOPROTEIN A; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; ELECTROPHORETIC MOBILITY; FEMALE; HUMAN; MALE; MEDICAL HISTORY; MOLECULAR WEIGHT; PHENOTYPE; POPULATION; SAMPLE SIZE; SEX DIFFERENCE; SPAIN; SYSTOLIC BLOOD PRESSURE; VENOUS BLOOD; WAIST HIP RATIO;

ADULT; AGED; AGED, 80 AND OVER; APOPROTEIN(A); ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEIN ISOFORMS; RANDOM ALLOCATION; SPAIN;

EID: 84877590008     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.01.006     Document Type: Article

References (39)

1. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340:14-22.
2. Hollander M., Bots M.L., Del Sol A.I., Koudstaal P.J., Witteman J.C., Grobbee D.E., Hofman A., Breteler M.M. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation 2002, 105:2872-2877.
3. Morito N., Inoue Y., Urata M., Yahiro E., Kodama S., Fukuda N., Saito N., Tsuchiya Y., Mihara H., Yamanouchi Y., Saku K., Urata H. Increased carotid artery plaque score is an independent predictor of the presence and severity of coronary artery disease. J Cardiol 2008, 51:25-32.
4. Polak J.F., Pencina M.J., Pencina K.M., O'Donnell C.J., Wolf P.A., D'Agostino R.B. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011, 365:213-221.
5. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
6. McLean J.W., Tomlinson J.E., Kuang W.J., Eaton D.L., Chen E.Y., Fless G.M., Scanu A.M., Lawn R.M. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987, 330:132-137.
7. Lackner C., Cohen J.C., Hobbs H.H. Molecular definition of the extreme size polymorphism in apolipoprotein (a). Hum Mol Genet 1993, 2:933-940.
8. Marcovina S.M., Hobbs H.H., Albers J.J. Relation between number of apolipoprotein (a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. Clin Chem 1996, 42:436-439.
9. Utermann G. Lipoprotein(a). The metabolic and molecular bases of inherited disease 2006, 2753-2787. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
10. Kraft H.G., Kochl S., Menzel H.J., Sandholzer C., Utermann G. The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum Genet 1992, 90:220-230.
11. Boerwinkle E., Leffert C.C., Lin J., Lackner C., Chiesa G., Hobbs H.H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations. J Clin Invest 1992, 90:52-60.
12. Anglés-Cano E., de la Peña Díaz A., Loyau S. Inhibition of fibrinolysis by lipoprotein(a). Ann N Y Acad Sci 2001, 936:261-275.
13. Paultre F., Tuck C.H., Boden-Albala B., Kargman D.E., Todd E., Jones J., Paik M.C., Sacco R.L., Berglund L. Relation of Apo (a) size to carotid atherosclerosis in an elderly multiethnic population. Arterioscler Thromb Vasc Biol 2002, 22:141-146.
14. Lundstam U., Herlitz J., Karlsson T., Lindén T., Wiklund O. Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med 2002, 251:111-118.
15. Lamon-Fava S., Marcovina S.M., Albers J.J., Kennedy H., Deluca C., White C.C., Cupples L.A., McNamara J.R., Seman L.J., Bongard V., Schaefer E.J. Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study. J Lipid Res 2011, 52:1181-1187.
16. Marcovina S.M., Albers J.J., Scanu A.M., Kennedy H., Giuculli F., Couderc R., Dati F., Rifai N., Sakurabayashi I., Tate J.R., Steinmetz A. Use of a reference material proposed by The International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein (a). Clin Chem 2000, 46:1956-1967.
17. Utermann G., Menzel H.J., Kraft H.G., Duba H.C., Kemmler H.G., Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp (a) lipoprotein concentrations in plasma. J Clin Invest 1987, 80:458-465.
18. Kraft H.G., Dieplinger H., Hoye E., Utermann G. Lp(a) phenotyping by immunoblotting with polyclonal and monoclonal antibodies. Arteriosclerosis 1988, 8:212-216.
19. Longenecker J.C., Klag M.J., Marcovina S.M., Liu Y.M., Jaar B.G., Powe N.R., Fink N.E., Levey A.S., Coresh J. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients. J Am Soc Nephrol 2005, 16:1794-1802.
20. El-Gendi S.S., Bakeet M.Y., El-Hamed E.A., Ibrahim F.K., Ahmed R. The value of lipoprotein (a), homocysteine, and Doppler of carotid and femoral arteries in assessment of atherosclerosis in asymptomatic cardiovascular risk patients. J Cardiol 2008, 52:202-211.
21. Denti L., Marchini L., Pasolini G., Baffoni M.T., Ablondi F., Valenti G. Lipoprotein Lp(a) and cerebrovascular disease in the elderly: correlations with the severity of extracranial carotid atherosclerosis assessed by ultrasonography. Acta Biomed Ateneo Parmense 1995, 66:175-183.
22. Raitakari O.T., Adams M.R., Celermajer D.S. Effect of Lp (a) on the early functional and structural changes of atherosclerosis. Arterioscler Thromb Vasc Biol 1999, 19:990-995.
23. Srámek A., Reiber J.H., Baak-Pablo R., Sturk A., Rosendaal F.R. Lipoprotein(a) and ultrasonographically determined early atherosclerotic changes in the carotid and femoral artery. J Thromb Haemost 2003, 1:374-379.
24. Grebe M.T., Schoene E., Schaefer C.A., Boedeker R.H., Kemkes-Matthes B., Voss R., Tillmanns H.H. Elevated lipoprotein (a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults. Atherosclerosis 2007, 190:194-198.
25. Kivimäki M., Magnussen C.G., Juonala M., Kähönen M., Kettunen J., Loo B.M., Lehtimäki T., Viikari J., Raitakari O.T. Conventional and Mendelian randomization analyses suggest no association between lipoprotein (a) and early atherosclerosis: the Young Finns Study. Int J Epidemiol 2011, 40:470-478.
26. Kotani K., Sakane N. Carotid intima-media thickness in asymptomatic subjects with low lipoprotein(a) levels. J Clin Med Res 2012, 4:130-134.
27. Emerging Risk Factors Collaboration, Erqou S., Kaptoge S., Perry P.L., Di Angelantonio E., Thompson A., White I.R., Marcovina S.M., Collins R., Thompson S.G., Danesh J. Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009, 302:412-423.
28. Danesh J., Collins R., Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000, 102:1082-1085.
29. Kamstrup P.R., Tybjaerg-Hansen A., Steffensen R., Nordestgaard B.G. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009, 301:2331-2339.
30. Marcovina S.M., Koschinsky M.L. Lipoprotein(a) concentration and apolipoprotein (a) size: a synergistic role in advanced atherosclerosis?. Circulation 1999, 100:1151-1153.
31. Rifai N., Ma J., Sacks F.M., Ridker P.M., Hernandez W.J., Stampfer M.J., Marcovina S.M. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: the Physicians' Health Study. Clin Chem 2004, 50:1364-1371.
32. Dieplinger B., Lingenhel A., Baumgartner N., Poelz W., Dieplinger H., Haltmayer M., Kronenberg F., Mueller T. Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease. Clin Chem 2007, 53:1298-1305.
33. Erqou S., Thompson A., Di Angelantonio E., Saleheen D., Kaptoge S., Marcovina S., Danesh J. Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants. J Am Coll Cardiol 2010, 55:2160-2167.
34. Kronenberg F., Kronenberg M.F., Kiechl S., Trenkwalder E., Santer P., Oberhollenzer F., Egger G., Utermann G., Willeit J. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation 1999, 100:1154-1160.
35. Marcovina S.M., Koschinsky M.L., Albers J.J., Skarlatos S. Report of the National Heart, Lung, and Blood Institute Workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions. Clin Chem 2003, 49:1785-1796.
36. Brown S.A., Morrisett J.D., Boerwinkle E., Hutchinson R., Patsch W. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb 1993, 13:1558-1566.
37. Helgadottir A., Gretarsdottir S., Thorleifsson G., Holm H., Patel R.S., Gudnason T., Jones G.T., van Rij A.M., Eapen D.J., Baas A.F., Tregouet D.A., Morange P.E., Emmerich J., Lindblad B., Gottsäter A., et al. Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol 2012, 60:722-729.
38. Abdullah M.H., Othman Z., Noor H.M., Arshad S.S., Yusof A.K., Jamal R., Rahman A.R. Peripheral blood gene expression profile of atherosclerotic coronary artery disease in patients of different ethnicity in Malaysia. J Cardiol 2012, 60:192-203.
39. Atkov O.Y., Gorokhova S.G., Sboev A.G., Generozov E.V., Muraseyeva E.V., Moroshkina S.Y., Cherniy N.N. Coronary heart disease diagnosis by artificial neural networks including genetic polymorphisms and clinical parameters. J Cardiol 2012, 59:190-194.